Document is current
Any future updates will be listed below
-
Authors
Zhao, Yuanhan
Lin, Ke
Zhang, Haocheng
Yuan, Guanmin
Zhang, Yanliang
Pan, Jingye
Hong, Liang
Huang, Yan
Ye, Ying
Huang, Lisu
Chen, Xiaohua
Liu, Jun
Li, Xiang
He, Xiaoju
Yue, Qiaoyan
Zhang, Hong
Zhou, Aiming
Zhuang, Yangyang
Chen, Jie
Wu, Caixia
Zhou, Wei
Cai, Fujing
Zhang, Shengguo
Li, Liang
Li, Shaling
Bian, Tingting
Li, Jiabin
Yin, Jun
Ruan, Zhengshang
Xu, Shanshan
Zhang, Yan
Chen, Jie
Zhang, Ying
Han, Jun
Su, Tingting
Tu, Fan
Jiang, Lijing
Lei, Chen
Du, Qiu
Ai, Jingwen
Zhang, Wenhong
-
Funding
Funding for this research was provided by:
Shanghai Science and Technology Committee (21Y11902100, 22YF1445800)
Jiangsu Research Hospital Association for Precision Medication (JY202101)
- License Information
-
More Information
Article History
Received: 29 April 2022
Accepted: 21 June 2022
First Online: 19 July 2022
Declarations
:
: An approval of both the study protocol and informed consent have been obtained from the Huashan Hospital Ethical committee (protocol ID: 2021-KY790). All patients will provide written informed consent. The physicians should obtain face to face informed consent during an interview before enrollment and provide the written form to Huashan PROGRESS project team.
: Not applicable.
: The authors declare that they have no competing interests.
